Characteristics of COVID-19 and Concomitant HBV Infection Characteristics of COVID-19 and Concomitant HBV Infection
This study details the epidemiology, clinical characteristics, treatment, and outcome of a cohort of patients with both SARS-CoV-2 and HBV infection.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 18, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Eliminating Hepatitis by 2030: HHS Releases New Strategic Plan Eliminating Hepatitis by 2030: HHS Releases New Strategic Plan
In an effort to counteract alarming trends in rising hepatitis infections, the HHS has developed and released its Viral Hepatitis National Strategic Plan 2021-2025.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 15, 2021 Category: Cancer & Oncology Tags: Infectious Diseases News Source Type: news

HCV Declines Level Off in HIV+ Men Who Have Sex With Men HCV Declines Level Off in HIV+ Men Who Have Sex With Men
The incidence of hepatitis C virus infection among HIV-positive men who have sex with men in the Netherlands fell once direct-acting antivirals became universally available in 2015, new findings show.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - January 11, 2021 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

SARS-CoV-2 Infection in Patients With Normal or Abnormal Liver SARS-CoV-2 Infection in Patients With Normal or Abnormal Liver
This paper summarizes what we know about SARS-CoV-2 in patients with liver disease, as well as its impact on the healthy liver. How should management of liver patients change in the COVID-19 era?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 11, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Health - January 11, 2021 Category: Consumer Health News Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Science - January 11, 2021 Category: Science Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

FDA Drug Safety Communication: FDA warns of serious liver injury risk with hepatitis C treatments Viekira Pak and Technivie
[10-22-2015] The U.S. Food and Drug Administration (FDA) is warning that hepatitis C treatments Viekira Pak and Technivie can cause severe liver injury mostly in patients with underlying advanced liver disease. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 7, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot
This article originally appeared on Akron Beacon Journal: Majority of Summit EMS workers opt out of COVID-19 vaccine ___ (c)2021 the Akron Beacon Journal (Akron, Ohio) Visit the Akron Beacon Journal (Akron, Ohio) at www.ohio.com Distributed by Tribune Content Agency, LLC. The post Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot appeared first on JEMS. (Source: JEMS Special Topics)
Source: JEMS Special Topics - January 7, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed EMS EMT Ohio Paramedic Source Type: news

Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot
This article originally appeared on Akron Beacon Journal: Majority of Summit EMS workers opt out of COVID-19 vaccine ___ (c)2021 the Akron Beacon Journal (Akron, Ohio) Visit the Akron Beacon Journal (Akron, Ohio) at www.ohio.com Distributed by Tribune Content Agency, LLC. The post Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot appeared first on JEMS. (Source: JEMS Operations)
Source: JEMS Operations - January 7, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed EMS EMT Ohio Paramedic Source Type: news

Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot
This article originally appeared on Akron Beacon Journal: Majority of Summit EMS workers opt out of COVID-19 vaccine ___ (c)2021 the Akron Beacon Journal (Akron, Ohio) Visit the Akron Beacon Journal (Akron, Ohio) at www.ohio.com Distributed by Tribune Content Agency, LLC. The post Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot appeared first on JEMS. (Source: JEMS: Journal of Emergency Medical Services News)
Source: JEMS: Journal of Emergency Medical Services News - January 7, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed EMS EMT Ohio Paramedic Source Type: news

Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot
This article originally appeared on Akron Beacon Journal: Majority of Summit EMS workers opt out of COVID-19 vaccine ___ (c)2021 the Akron Beacon Journal (Akron, Ohio) Visit the Akron Beacon Journal (Akron, Ohio) at www.ohio.com Distributed by Tribune Content Agency, LLC. The post Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot appeared first on JEMS. (Source: JEMS Latest News)
Source: JEMS Latest News - January 7, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed EMS EMT Ohio Paramedic Source Type: news

Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot
This article originally appeared on Akron Beacon Journal: Majority of Summit EMS workers opt out of COVID-19 vaccine ___ (c)2021 the Akron Beacon Journal (Akron, Ohio) Visit the Akron Beacon Journal (Akron, Ohio) at www.ohio.com Distributed by Tribune Content Agency, LLC. The post Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot appeared first on JEMS. (Source: JEMS Administration and Leadership)
Source: JEMS Administration and Leadership - January 7, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed EMS EMT Ohio Paramedic Source Type: news

Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot
This article originally appeared on Akron Beacon Journal: Majority of Summit EMS workers opt out of COVID-19 vaccine ___ (c)2021 the Akron Beacon Journal (Akron, Ohio) Visit the Akron Beacon Journal (Akron, Ohio) at www.ohio.com Distributed by Tribune Content Agency, LLC. The post Majority of Summit (OH) EMS Workers Opt Out of COVID-19 Shot appeared first on JEMS. (Source: JEMS Patient Care)
Source: JEMS Patient Care - January 7, 2021 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed EMS EMT Ohio Paramedic Source Type: news

Broadening participation in clinical trials: A win for all
The objective is to engage in rea l-world, evidence-based research and bring trials to the local community, where a significant proportion of cancer care is rendered,” he adds.   To help, Cardinal Health ’s real-world evidence and insights teams analyze the real-world data collected from the sites, which can be compared to results from clinical trials to demonstrate the real-world value of therapies.   By bringing these studies to the community, many of the usual challenges are overcome, adds Gajra. These include trial site location (typically academic institutions) and the distances that ...
Source: EyeForPharma - January 6, 2021 Category: Pharmaceuticals Authors: Joseph Constance Source Type: news

Comunicado de la FDA sobre la seguridad de los medicamentos: Informaci & oacute;n actualizada sobre la interacci & oacute;n entre el medicamento Victrelis (boceprevir) y ciertos medicamentos reforzados inhibidores de la proteasa del VIH
El 26 de abril del 2012, la Administraci ón de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) informó al público que, en estos momentos, no se recomienda tomar conjuntamente Victrelis (boceprevir), un inhibidor de la proteasa del virus de la hepatitis C (VHC) junto con ciertos inhibidores de la proteasa del virus de la inmunodeficiencia humana VIH reforzados con ritonavir, por la posibilidad de reducir la eficacia de los medicamentos, lo que puede desencadenar el aumento del VHC o VIH en la sangre (carga viral). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 6, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

NUS researchers develop foldable tent for safe dental care during the pandemic
National University of SingaporeScience Business AnnouncementIMAGE: The Dental Droplet and Aerosol Reducing Tent (Dental DART) was developed by NUS researchers (from left) Professor Freddy Boey, Mr Sudarshan Anantharaman, Associate Professor Vinicius Rosa and their team.viewmore Credit: National University of SingaporeDental treatments are performed at close proximity to the mouths and noses of the patients, and the procedures are often related to the generation of aerosols as well as handling of oral fluids and blood. This puts dentists at a high risk of exposure to COVID-19, and other critical infectious diseas...
Source: Dental Technology Blog - January 6, 2021 Category: Dentistry Source Type: news

DURECT Corporation Appoints Two New Board Members
CUPERTINO, Calif., Jan. 5, 2021 -- (Healthcare Sales & Marketing Network) -- DURECT Corporation (Nasdaq: DRRX) today announced the appointment of two new members to its board of directors, Gail J. Maderis, MBA and Mohammad Azab, M.D., M. Sc., MBA, two sen... Biopharmaceuticals, Drug Delivery, Personnel DURECT, hepatitis, non-alcoholic steatohepatitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 5, 2021 Category: Pharmaceuticals Source Type: news

Don ’t Let the Pandemic Stop Your Shots
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That ’s not wise, health experts say. (Source: NYT Health)
Source: NYT Health - December 28, 2020 Category: Consumer Health News Authors: Paula Span Tags: your-feed-science Whooping Cough Shingles (Disease) Diphtheria Coronavirus (2019-nCoV) Influenza Elderly Epidemics Drugs (Pharmaceuticals) Pneumonia your-feed-healthcare Vaccination and Immunization Hepatitis Tetanus Minorities Source Type: news

Is Hepatitis Contagious Hep C Hepatitis A B
Is Hepatitis Contagious? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 22, 2020 Category: General Medicine Source Type: news

Nobel Prize reflects perseverance in scientific research
(Mary Ann Liebert, Inc./Genetic Engineering News) New Rochelle, NY, December 21, 2020--The 2020 Nobel Prize in Physiology or Medicine went to three researchers for their discovery of hepatitis C virus (HCV). The undying perseverance that it took to find and cure this elusive virus (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 21, 2020 Category: Cancer & Oncology Source Type: news

Kidney Transplant Outcomes Similar With Hep C+ Donors
FRIDAY, Dec. 18, 2020 -- Recipients of kidneys from donors infected with hepatitis C virus (HCV) have similar kidney allograft function and probability of rejection in the first year after transplantation as those who receive kidneys from donors... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 18, 2020 Category: Pharmaceuticals Source Type: news

Needs of Individuals Living With Hepatitis Delta Virus and Their Caregivers, 2016-2019
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - December 17, 2020 Category: International Medicine & Public Health Tags: Public Health Source Type: news

One-Year Transplant Outcomes Similar With Kidneys From HCV+, HCV- Donors One-Year Transplant Outcomes Similar With Kidneys From HCV+, HCV- Donors
Outcomes for renal transplants from hepatitis C virus (HCV)-infected donors to HCV-negative recipients are similar to those for HCV-negative patients who receive kidneys from donors without HCV, according to a one-year follow-up study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - December 16, 2020 Category: Surgery Tags: Nephrology News Source Type: news

New viral detection technique uses smartphone camera to diagnose various infections
(American Association for the Advancement of Science) Scientists have developed a novel smartphone-based technique to diagnose viral infections that uses a deep learning algorithm to identify viruses in metal nanoparticle-labeled samples, enabling rapid virus detection without the need for skilled laboratory workers and expensive equipment. The system correctly identified clinically relevant concentrations of Zika, hepatitis B (HBV), or hepatitis C (HCV) in 134 patient samples with 98.97% sensitivity. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 16, 2020 Category: Infectious Diseases Source Type: news

USPSTF Recommends Hep B Screen for At-Risk Teens, Adults
TUESDAY, Dec. 15, 2020 -- The U.S. Preventive Services Task Force (USPSTF) concludes that screening adults and adolescents at increased risk for hepatitis B virus (HBV) infection has moderate net benefit. These findings form the basis of a final... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 15, 2020 Category: Pharmaceuticals Source Type: news

COVID-19: impact on STIs, HIV and viral hepatitis, PHE
This report assesses the impact of the COVID-19 pandemic on prevention, testing, diagnosis and care for STIs, HIV and hepatitis in England to date. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 15, 2020 Category: Consumer Health News Source Type: news

USPSTF statement on screening for hepatitis B virus infection in adolescents, adults
(JAMA Network) The   US Preventive Services Task Force (USPSTF) recommends screening for hepatitis B virus   infection in adolescents and adults at increased risk for infection.   (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 15, 2020 Category: Infectious Diseases Source Type: news

The Ambulance Science Podcast: Make Up Your Own Mind About the Vaccine
Get every episode of The Ambulance Science Podcast by subscribing to Apple Podcasts or Google Podcasts. Where I’m coming from (compared to most of my colleagues): Master’s in Public Health with a concentration in Health Policy from Yale Medical School.FT Faculty at GWU School of Medicine & Southern Connecticut State University MPH Program, and long-time adjunct faculty at NYMC MPH program in Health Policy.Assistant Commissioner of Health at the NYC Department of Health & Mental Hygiene during the first SARS outbreak.Served as State EMS Director, Consultant to Public Health ...
Source: JEMS Special Topics - December 14, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Podcasts Ambulance Science Source Type: news

One-year kidney allograft outcomes do not differ by hepatitis C status of donor
(National Kidney Foundation) Study published in AJKD shows that kidney allograft outcomes one year post-transplantation in hepatitis C virus (HCV)-negative recipients do not differ by the HCV status of the donor. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 14, 2020 Category: Infectious Diseases Source Type: news

CDC, HHS: Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT); Notice of Charter Renewal
The Centers for Disease Control and Prevention (CDC) announces the renewal of the CDC/Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT) charter. The charter is effective for a 2-year period through November 25, 2022. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - December 11, 2020 Category: Rural Health Source Type: news

Gilead Sciences acquires German biotech company for $1.39 billion
The acquisition aims to boost Gilead ’s development and commercialization of therapeutics for treating the chronic hepatitis delta virus. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 10, 2020 Category: Biotechnology Authors: Dawn Kawamoto Source Type: news

Nobel Laureates on their Hunt for the Cure Nobel Laureates on their Hunt for the Cure
The 2020 Nobel Prize in Medicine is awarded to three scientists who discovered hepatitis C, an RNA virus that was curbed by common-sense public health measures before new antivirals could save lives.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 9, 2020 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Cannabis Use and Diabetes Risk in Chronic HCV Infection Cannabis Use and Diabetes Risk in Chronic HCV Infection
This study suggests a potential protective effect of cannabis on the risk of diabetes in patients with chronic hepatitis C. What might be the mechanism behind this beneficial effect?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 9, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Hepatitis A in the US: Mayo Clinic Radio Health Minute
Recently, the Centers for Disease Control and Prevention released information about hepatitis A outbreaks among drug users and homeless people in certain U.S. cities. In this Mayo Clinic Radio Health Minute, we learn more about the disease from Dr. Stacey Rizza, a Mayo Clinic infectious disease specialist. To listen, click the link below. Hepatitis A in [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 9, 2020 Category: Databases & Libraries Source Type: news

Hep C Testing, Identification Plummet During COVID-19
TUESDAY, Dec. 8, 2020 -- The COVID-19 systematic emergency response has led to a decrease in hepatitis C virus (HCV) testing and identification, according to a study published online Nov. 22 in the Journal of Primary Care& Community... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 8, 2020 Category: Pharmaceuticals Source Type: news

Targeting the ion channel TRPM7 promotes the thymic development of regulatory T cells by promoting IL-2 signaling
The thymic development of regulatory T (Treg) cells, crucial suppressors of the responses of effector T (Teff) cells, is governed by the transcription factor FOXP3. Despite the clinical importance of Treg cells, there is a dearth of druggable molecular targets capable of increasing their numbers in vivo. We found that inhibiting the function of the TRPM7 chanzyme (ion channel and enzyme) potentiated the thymic development of Treg cells in mice and led to a substantially higher frequency of functional Treg cells in the periphery. In addition, TRPM7-deficient mice were resistant to T cell–driven hepatitis. Deletion of ...
Source: Signal Transduction Knowledge Environment - December 8, 2020 Category: Science Authors: Mendu, S. K., Stremska, M. E., Schappe, M. S., Moser, E. K., Krupa, J. K., Rogers, J. S., Stipes, E. J., Parker, C. A., Braciale, T. J., Perry, J. S. A., Desai, B. N. Tags: STKE Research Articles Source Type: news

Violence and hepatitis C transmission in prison-a modified social ecological model - Sazzad HMS, McCredie L, Treloar C, Lloyd AR, Lafferty L.
BACKGROUND: Transmission of hepatitis C virus (HCV) among the prisoner population is most frequently associated with sharing of non-sterile injecting equipment. Other blood-to-blood contacts such as tattooing and physical violence are also common in the... (Source: SafetyLit)
Source: SafetyLit - December 5, 2020 Category: International Medicine & Public Health Tags: Violence and Weapons Issues Source Type: news

NIDCR's Winter 2020 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Winter 2020 E-Newsletter In this issue: NIDCR News Funding Opportunities NIH/HHS News Funding Notices Science Advances Subscribe to NICDR News Grantee News   NIDCR News NIDCR Welcomes New Director Rena D’Souza Rena N. D’Souza, DDS, MS, PhD, was sworn in as the director of NIDCR by NIH Director Francis S. Collins, MD, PhD, on October 13. Prior to joining NIH, Dr. D’Souza was the assistant vice president for academic affairs and education for health s...
Source: NIDCR Science News - December 4, 2020 Category: Dentistry Source Type: news

COVID-19 pandemic responsible for decrease in hepatitis C testing
(Boston Medical Center) New research from Boston Medical Center finds that the COVID-19 emergency systemic changes made to decrease in-person visits during the pandemic have led to a decrease in hospital-wide Hepatitis C (HCV) testing by 50 percent, and a reduction in new HCV diagnoses by more than 60 percent. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 4, 2020 Category: International Medicine & Public Health Source Type: news

Early antiviral treatment in chronic hepatitis  B saves lives and costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2020 Category: Drugs & Pharmacology Source Type: news

Improving access to hepatitis  C treatment in Pakistan: important role of generics
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2020 Category: Drugs & Pharmacology Source Type: news

Acute hepatitis E – Burkina Faso
Between 8 September and 24 November, 2020, the North-Central region of Burkina Faso reported a (Source: WHO Disease Outbreaks)
Source: WHO Disease Outbreaks - November 27, 2020 Category: Infectious Diseases Tags: news Source Type: news

Patients Cured of HCV Still at High Liver Cancer Risk Patients Cured of HCV Still at High Liver Cancer Risk
The burden of hepatocellular carcinoma (HCC) appears likely to move from patients who currently have hepatitis C virus (HCV) infection to those who have previously been cured, a new modeling study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 26, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Many Infants With Hep C-Positive Moms Not Screened for HCV
WEDNESDAY, Nov. 25, 2020 -- Less than one-third of infants born to mothers with hepatitis C virus infection (HCV+) receive appropriate HCV follow-up testing, according to a study presented at The Liver Meeting, the annual meeting of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 25, 2020 Category: Pharmaceuticals Source Type: news

Health and care heroes honoured in parliamentary awards
Doctors and nurses working to combat Hepatitis C in the homeless during the pandemic, the team behind the UK ’s first virtual reality lung rehabilitation programme launched this year and the research team working on the COVID-19 vaccine have all been recognised in the regional round of the NHS parliamentary awards. (Source: NHS Networks)
Source: NHS Networks - November 24, 2020 Category: UK Health Source Type: news

Determinants of Stigma Among Patients With HCV Infection Determinants of Stigma Among Patients With HCV Infection
Many patients with HCV infection experience stigma, which can be an important barrier to HCV treatment and elimination. What factors are associated with HCV-related stigma?Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 20, 2020 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news

Aspirin and Statins in Chronic Hepatitis B: It's Complicated Aspirin and Statins in Chronic Hepatitis B: It's Complicated
Statins play a bigger part than aspirin in reducing risk for hepatocellular carcinoma in patients with hepatitis B, new research shows, and cirrhosis seems to cancel any beneficial effect of aspirin.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 19, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Opt-Out Policy Increased HIV/HCV Testing Opt-Out Policy Increased HIV/HCV Testing
Bundled opt-out HIV/hepatitis C virus (HCV) testing increased the percentage of syringe service program (SSP) clients who received HIV and HCV rapid tests at enrollment into the program.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 19, 2020 Category: Gastroenterology Tags: Infectious Diseases News Source Type: news

Vanquishing Hepatitis C: A Remarkable Success Story Vanquishing Hepatitis C: A Remarkable Success Story
A look back at one of the singular achievements in medical research of the past 25 years, and what improvements are still to come.Medscape Gastroenterology (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - November 17, 2020 Category: Transplant Surgery Tags: Gastroenterology Commentary Source Type: news

X-ray study explores potential of hepatitis C drugs to treat COVID-19
(DOE/Oak Ridge National Laboratory) Researchers at the Department of Energy's Oak Ridge National Laboratory investigated the binding properties of several hepatitis C drugs to determine how well they inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce. Inhibiting, or blocking, the protease from functioning is vital to stopping the virus from spreading in patients with COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 16, 2020 Category: Infectious Diseases Source Type: news